KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Schrodinger (SDGR) Accumulated Expenses (2019 - 2025)

Schrodinger (SDGR) has disclosed Accumulated Expenses for 7 consecutive years, with $39.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 6.76% to $39.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.3 million, a 6.76% decrease, with the full-year FY2025 number at $39.3 million, down 6.76% from a year prior.
  • Accumulated Expenses was $39.3 million for Q4 2025 at Schrodinger, up from $28.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $42.1 million in Q4 2024 to a low of $10.3 million in Q1 2021.
  • A 5-year average of $22.5 million and a median of $21.4 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 118.02% in 2021, then fell 16.74% in 2025.
  • Schrodinger's Accumulated Expenses stood at $18.4 million in 2021, then surged by 35.19% to $24.9 million in 2022, then rose by 27.65% to $31.8 million in 2023, then soared by 32.58% to $42.1 million in 2024, then fell by 6.76% to $39.3 million in 2025.
  • Per Business Quant, the three most recent readings for SDGR's Accumulated Expenses are $39.3 million (Q4 2025), $28.0 million (Q3 2025), and $25.3 million (Q2 2025).